Journal
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY
Volume 69, Issue 3, Pages 471-480Publisher
AMER PSYCHOLOGICAL ASSOC
DOI: 10.1037/0022-006X.69.3.471
Keywords
-
Categories
Funding
- NIDA NIH HHS [R01 DA008511-07, DA08511] Funding Source: Medline
Ask authors/readers for more resources
Cigarette smokers with past major depressive disorder (MDD) received 8 group sessions of standard, cognitive-behavioral smoking cessation treatment (ST; n = 93) or standard, cognitive-behavioral smoking cessation treatment plus cognitive-behavioral treatment for depression (CBT-D; n = 86). Although abstinence rates were high in both conditions (ST, 24.7%; CBT-D, 32.5%, at 1 year) for these nonpharmacological treatments, no main effect of treatment was found. However, secondary analyses revealed significant interactions between treatment condition and both recurrent depression history and heavy smoking (greater than or equal to 25 cigarettes a day) at baseline. Smokers with recurrent MDD and heavy smokers who received CBT-D were significantly more likely to be abstinent than those receiving ST (odds ratios = 2.3 and 2.6, respectively). Results suggest that CBT-D provides specific benefits for some, but not all, smokers with a history of MDD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available